ABUS EBITDA Margin
Arbutus Biopharma Corp · EBITDA Margin
ABUS EBITDA Margin
Latest reported84.29%period ending
ABUS TTM EBITDA Margin (-24.55% → 84.29%)
TTM ebitda margin
High-resolution chart · PNG
ABUS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 84.2912% | |
| 84.0189% | |
| -234.6162% | |
| -305.6894% | |
| -365.1596% | |
| -1,222.2552% | |
| -1,159.7634% | |
| -1,133.1207% | |
| -762.6677% | |
| -569.1283% | |
| -398.203% | |
| -326.9772% | |
| -296.7028% | |
| -200.9811% | |
| -156.8185% | |
| -168.7576% | |
| -185.4262% | |
| -307.8766% | |
| -643.8023% | |
| -651.5932% | |
| -784.2893% | |
| -802.4283% | |
| -834.3506% | |
| -889.603% | |
| -1,705.3097% | |
| -2,071.7719% | |
| -2,524.8212% | |
| -2,581.3375% | |
| -1,988.6665% | |
| -1,686.5459% | |
| -1,370.7485% | |
| -1,814.7919% | |
| -876.4001% | |
| -881.5814% | |
| -994.8131% | |
| -827.6628% | |
| -4,012.1964% | |
| -6,706.2333% | |
| -4,877.0624% | |
| -407.0763% | |
| -302.8704% | |
| -234.827% | |
| -167.8009% | |
| -287.5189% | |
| -237.2752% | |
| -231.5686% | |
| -216.9665% | |
| -132.9182% | |
| -124.9012% | |
| -82.1589% | |
| -74.8456% | |
| -128.369% | |
| -110.628% | |
| -99.0394% | |
| -85.9849% | |
| -60.8107% | |
| -55.7318% | |
| -59.6346% | |
| -59.5474% | |
| -78.6409% | |
| -63.1986% | |
| -68.9145% | |
| -80.1789% | |
| -59.4997% | |
| -91.3869% | |
| -69.7657% | |
| -50.9688% | |
| -43.0763% | |
| -42.4558% | |
| -79.0769% | |
| -75.9347% | |
| -100.9254% | |
| -60.9335% | |
| -24.5544% |